Association of LPA variants with risk of coronary disease and the implications for lipoprotein (a)-lowering therapies: a Mendelian randomization analysis

S Burgess, BA Ference, JR Staley, DF Freitag… - JAMA …, 2018 - jamanetwork.com
Importance Human genetic studies have indicated that plasma lipoprotein (a)(Lp [a]) is
causally associated with the risk of coronary heart disease (CHD), but randomized trials of …

Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians

MB Lanktree, SS Anand, S Yusuf… - Circulation …, 2010 - Am Heart Assoc
Background—Functional copy number variation in the apolipoprotein (a) gene (LPA)
underlies a variable number of protein kringle domains repeated in tandem in the lipoprotein …

Validation and quantification of genetic determinants of lipoprotein-a levels and predictive value for angiographic coronary artery disease

JL Anderson, S Knight, HT May, BD Horne… - The American Journal of …, 2013 - Elsevier
Lipoprotein (a)(Lp [a]) has gained attention as a heritable coronary artery disease (CAD) risk
factor and therapeutic target. Two genetic variants in the LPA gene have been reported to …

Lipoprotein (a) as a potential causal genetic risk factor of cardiovascular disease: a rationale for increased efforts to understand its pathophysiology and develop …

S Tsimikas, JL Hall - Journal of the American College of Cardiology, 2012 - jacc.org
Recent published studies have provided increasing evidence that lipoprotein (a)[Lp (a)] may
be a potential causal, genetic, independent risk factor for cardiovascular disease (CVD). Lp …

A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms [S]

S Mack, S Coassin, R Rueedi, NA Yousri… - Journal of lipid …, 2017 - ASBMB
High lipoprotein (a)[Lp (a)] concentrations are an independent risk factor for cardiovascular
outcomes. Concentrations are strongly influenced by apo (a) kringle IV repeat isoforms. We …

Meta analysis of candidate gene variants outside the LPA locus with Lp (a) plasma levels in 14,500 participants of six White European cohorts

D Zabaneh, M Kumari, M Sandhu, N Wareham… - Atherosclerosis, 2011 - Elsevier
BACKGROUND: Both genome-wide association studies and candidate gene studies have
reported that the major determinant of plasma levels of the Lipoprotein (a)[Lp (a)] reside …

LPA Gene, Ethnicity, and Cardiovascular Events

SR Lee, A Prasad, YS Choi, C Xing, P Clopton… - Circulation, 2017 - Am Heart Assoc
Background: The relationship of LPA single nucleotide polymorphisms (SNPs),
apolipoprotein (a) isoforms, and lipoprotein (a)[Lp (a)] levels with major adverse …

Evaluating genetically-predicted causal effects of lipoprotein (a) in human diseases: a phenome-wide Mendelian randomization study

J Shi, SS Shringarpure, D Hinds… - medRxiv, 2024 - medrxiv.org
Background: Lipoprotein (a)(Lp [a]) is a circulating plasma lipoprotein that is emerging as an
important independent risk factor for vascular disease. Lp (a) levels are 75-90% heritable …

LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia

M Paquette, S Bernard, G Thanassoulis… - Journal of Clinical …, 2019 - Elsevier
Background In recent years, lipoprotein (a)(Lp (a)) has been recognized as an important risk
factor for cardiovascular disease (CVD). A variant in the LPA gene, rs10455872, has been …

Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels

W Lu, YC Cheng, K Chen, H Wang… - Human molecular …, 2015 - academic.oup.com
Abstract Lipoprotein (a)[Lp (a)] is an independent risk factor for atherosclerosis-related
events that is under strong genetic control (heritability= 0.68–0.98). However, causal …